arrow
M

Michael K. Pugsley

toxicology and safety pharmacology
H指数:31
被引数:3,787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regulatory safety pharmacology & toxicology assessment studies: Measurement of the ECG and hemodynamic parameters in nonrodent species

安全性药理学与毒理学评价研究:非啮齿类物种的心电图和血流动力学参数测量

2025-09-010
PRE
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation

重新评估ICH S7A核心组中的安全性药理学呼吸研究:一项多公司评估,评估其非临床效用和临床转化

2025-09-010
PRE
QT risk assessment for the development of oligonucleotide therapeutics - An industry survey sponsored by the Safety Pharmacology Society (SPS) ion channel working group and oligonucleotide safety working group

寡核苷酸治疗药物开发的QT风险评估——由安全药理学学会(SPS)离子通道工作组与寡核苷酸安全性工作组赞助的行业调查

2025-09-010
PRE
Characterization of vasoactive agents in a canine safety pharmacology PKPD model: A HESI initiative

血管活性剂在犬安全性药理学PKPD模型中的表征:一项HESI倡议

2025-09-010
PRE
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As (vol 123, 107270, 2023)

非啮齿类动物非临床在体心血管遥测研究最佳实践考量:提供高质量QTc数据以支持ICH E14/S7B答疑(卷123,107270,2023)

2025-09-010
OAAI
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation

重新评估ICH S7A核心电池内的安全药理学呼吸研究: 临床前效用和临床翻译的多公司评估

2024-11-010
PRE
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation
2020-06-0127
OAAI